Biostock publishes an article describing how Prolight scales-up cartridge manufacturing

Biostock publishes an article describing how  Prolight continues to make important progress in the scale-up of the manufacturing line for the system’s single-use cartridges. This is a critical step in securing the volumes required for the upcoming clinical performance study. BioStock talked to COO Karl Bullen to learn more.

Read the full article here: https://biostock.se/en/2026/02/prolight-skalar-upp-tillverkningen-av-testkort/

For further information, please contact:
Ulf Bladin, CEO
E-mail: info@prolightdx.com
Phone: +46 73 582 39 87
Company website: www.prolightdx.com

About Us
Prolight Diagnostics AB develops innovative Point-of-Care systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events. Our launch product will be for the measurement of high sensitive troponin, to aid in the rule-in and rule-out of myocardial infarction.
 
The company’s share is traded on the NGM Nordic SME marketplace, under the ticker PRLD.

Attachments
Biostock publishes an article describing how Prolight scales-up cartridge manufacturing

Biostock publishes an article describing how Prolight scales-up cartridge manufacturing
Back